Prosecution Insights
Last updated: May 29, 2026
Application No. 17/881,567

Concentrated Liquid Detergent

Non-Final OA §103§DOUBLEPATENT
Filed
Aug 04, 2022
Priority
Aug 04, 2021 — provisional 63/229,298
Examiner
ASDJODI, MOHAMMADREZA
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Henkel AG & Co. KGaA
OA Round
3 (Non-Final)
59%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
479 granted / 810 resolved
-5.9% vs TC avg
Strong +47% interview lift
Without
With
+47.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
26 currently pending
Career history
840
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
80.6%
+40.6% vs TC avg
§102
5.8%
-34.2% vs TC avg
§112
0.9%
-39.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 810 resolved cases

Office Action

§103 §DOUBLEPATENT
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-3, 5, 8-13, 15, 17 and 20-26 are rejected under 35 U.S.C. 103 as being unpatentable over Piorkowski (US 2018/0334641 A1) in view of OH et al. (US 2016/0213597 A1), as evidenced by Chemical information of ethylene glycol monohexylether’s properties (ethylene glycol monohexyl ether properties and applications - Google Search). Regarding claims 1, 3, 6, 10-12, 15, Piorkowski teaches a water soluble unit dose detergent pouch, or pack; [abstract, 2-3, 7-8], comprising; A)- 1)- a surfactant system including alcohol ethoxy sulfate (instant claim 10), AES is of formula (I), such as sodium lauryl ether sulfate containing 1-6 moles of ethylene oxide; [29, 107, 122], in amounts of 20-40%; [39], 2)- nonionic surfactant of ethoxylated alcohol (instant claim 11) in amount of 30-70%; [40], AE surfactants are C12-14 alcohols containing 3-8 moles of ethylene oxide; [128-130], and 3)- linear alkylbenzene sulfonate (claim s 11-12 in the amount of in the amounts of 10-20%; [38], B)-water in an amount as low as 5% by weight; [12], and C)- rheology control (viscosity) modifier (instant 3, 5 and 17) such as polyoxyalkelene sorbitol fatty acid ester; [31, claim 13]. Furthermore, it teaches other viscosity control agents of less than 20% by weight of a non-aqueous solvent, polyalkyleneglycol (i.e. a rheology control agent); [1-82 and Table 1], that the composition contains 4-6% by weight of glycol ethers, such as butyl cellosolve and butyl carbitol ( i.e. a rheology control agent; [92-93 and Table 1]. Regarding claims 1, 13 and 15, Piorkowski-641 does not teach the ethylene glycol monohexylether rheology modifier. However, the analogous art of OH et al. teaches a treatment and cleaning composition for laundry and household comprising ethylene glycol monohexylether both as a nonionic surfactant and effective solvent in aqueous and hydrophobic solutions; [86, 49-50]. It would have been obvious, before the effective filing date, to add the ethylene glycol monohexylether of OH to Piorkowki with the motivation of enhancing the removal of both water soluble and water insoluble soil materials from fabric and household surfaces. This is further evidenced by data sheet(s) on properties of ethylene glycol monohexylether or any Textbook on Organic Chemistry. Regarding claims 8-9 and 11-12, It should be noted that the amounts of individual surfactant (1) 20-40%, (2) 30-70%, (3) 10-20% correspondingly, and thus their ratios are not anticipatory, however there are a major overlapping ranges of condition between the prior art and the instant claims that renders them completely obvious. Please note that, it would have been obvious to one of ordinary skill in the art at the time of invention (before the effective filing date of the invention) to have selected the overlapping portion of the ranges disclosed by the reference because overlapping ranges have been held to be a prima facie case of obvious. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). See MPEP § 2144.05. Regarding claims 2, 13, 21-22 and 24-25, The Office realizes that all the claimed effects or physical properties, dynamic viscosity of less than 400 cps, are not positively stated by the reference. However, the reference teaches all of the claimed reagents, in the claimed ranges, was prepared under similar conditions, and that the original specification specifies that the properties arise from a combination of specific ingredients or process step and that it is rendered obvious by the applied art. Therefore, the claimed effects and physical properties, i.e. viscosity of less than 400 cps, would expectedly be achieved by a composition with all the claimed ingredients. If it is the applicants’ position that this would not be the case: (1) evidence would need to be presented to support applicant’s position; and (2) it would be the Office’s position that the application contains inadequate disclosure that there is no teaching as to how to obtain the claimed properties and effects with only the claimed ingredients. “Products of identical chemical composition cannot have mutually exclusive properties.” A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990) [see MPEP 2112.01]. Regarding claim 20, Transitional phrase “consisting essentially of” occupies a middle ground between closed claims that are written in a consisting of’ format and fully open claims that are drafted in a comprising’ format.” PPG Industries v.Guardian Industries, 156 F.3d 1351, 1354, 48 USPQ2d 1351, 1353-54 (Fed. Cir.1998). See also Atlas Powder v. E.I. duPont de Nemours & Co., 750 F.2d 1569,224 USPQ 409 (Fed. Cir. 1984); In re Janakirama-Rao, 317 F.2d 951, 137 USPQ893 (CCPA 1963); Water Technologies Corp. vs. Calco, Ltd., 850 F.2d 660, 7USPQ2d 1097 (Fed. Cir. 1988). [MPEP 2111.03 R3]. For the purposes of searching for and applying prior art under 35 U.S.C. 102 and 103, absent a clear indication in the specification or claims of what the basic and novel characteristics actually are, “consisting essentially of” will be construed as equivalent to “comprising.” Regarding claims 23 and 26, Piorkowski does not mandate any other solvent in addition to water and rheology control agent; [claim 23]. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 10 of U.S. Patent No. 11,447,727 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because U.S. Patent No. 11,447,727 B2 claims a very similar unit dose composition comprising water in an amount as low as 5% by weight, same surfactant components and the viscosity. Claims 1-2, 13 and 20 correspond to claims 1 and 10-11 of U.S. Patent No. 11,447,727 B2 which identical in scope. Response to Arguments Applicant’s arguments with respect to priority date of Piorkowski-314 A1 is persuasive and thus a new ground of rejection is provided. This is a non-final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to Dr. M. Reza Asdjodi whose telephone number is (571)270-3295. The examiner can normally be reached on 10 AM- 8 PM Flex.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Dr. Mark Eashoo can be reached on 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /M.R.A./ Examiner, Art Unit 1767 2026/01/31 /MARK EASHOO/Supervisory Patent Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Aug 04, 2022
Application Filed
Feb 13, 2025
Non-Final Rejection mailed — §103, §DOUBLEPATENT
Jul 15, 2025
Response Filed
Oct 23, 2025
Final Rejection mailed — §103, §DOUBLEPATENT
Dec 24, 2025
Response after Non-Final Action
Feb 04, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637637
METAL COACH
1y 0m to grant Granted May 26, 2026
Patent 12630785
LIQUID FABRIC CARE COMPOSITIONS COMPRISING CAPSULES
2y 3m to grant Granted May 19, 2026
Patent 12630787
LIQUID LAUNDRY DETERGENT FORMULATION
2y 7m to grant Granted May 19, 2026
Patent 12606780
Soluble Laundry Detergent Sheets With Acrylamide Polymers
5y 0m to grant Granted Apr 21, 2026
Patent 12595439
Concentrated Flowable Washing Agent Preparation Having Improved Properties
4y 6m to grant Granted Apr 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
59%
Grant Probability
99%
With Interview (+47.3%)
2y 10m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 810 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month